Samaneh Salarvand

6PUBLICATIONS
16CO-AUTHORS
Social epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 22, 2026
The Utility of HER2 Overexpression in Prognosis of Gastric Cancer: A Systematic Review and Meta-Analysis Study.

|May 04, 2026
A Rare Case of P-Null Phenotype Identified During Preoperative Screening.

|Feb 25, 2026
Curcumin therapeutic potential in gastric cancer prevention, treatment and metastasis suppression.

Alireza Abdollahi, Samaneh Salarvand, Fereshteh Ameli

|Aug 25, 2025
Human Epidermal Growth Factor Receptor 2 [HER-2/neu] Amplification and Microsatellite Stable Status in Gastric and Gastroesophageal Adenocarcinoma: Assessing Frequency and Prognostic Implications at the Cancer Institute of Iran.

Samaneh Salarvand, Abbas Mohammadi, Reza Shahsiah

|Aug 04, 2025
Hemolytic Transfusion Reaction due to Anti Jk Antibody, a Frequently Transient and Low-Titer Antibody Probably Not Detected in Pretransfusion Testing; A Case Report.

Samaneh Salarvand, Aysan Nozheh, Alireza Abdollahi

|Feb 04, 2024
Frequency and Underlying Causes of Alloimmunization Against Red Blood Cell Antigens in Patients Referred to the Blood Bank of the Tertiary Referral Hospital of Tehran from 2018 to 2020.

Samaneh Salarvand, Samira Moeini Nasab, Alireza Abdollahi

Pageof 1

Frequent Collaborators

3 joint publications

Aysan Nozheh

2 joint publications

Alireza Abdollahi

2 joint publications

Reza Ghalehtaki

1 joint publications

Zohreh Nozarian